News on MAJOR PHARMACEUTICALS from BioPortfolio.com http://www.BioPortfolio.com Consolidated MAJOR PHARMACEUTICALS news from BioPortfolio.com Tue, 09 Feb 2010 22:17:20 GMT en Endo Pharmaceuticals Completes Secondary Offerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036039&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036039&THISHREF=http://c.moreover.com/click/here.pl%3fz2536476930%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036039&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036039&THISHREF=http://c.moreover.com/click/here.pl%3fz2536476930%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCitybizlist: Reportlinker Adds Kinase Therapeutics: Pipeline Assessment and Commercial Prospects - Overviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037184&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037184&THISHREF=http://c.moreover.com/click/here.pl%3fz2536937672%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037184&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037184&THISHREF=http://c.moreover.com/click/here.pl%3fz2536937672%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: King Pharmaceuticals Appoints Two New Members to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038118&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038118&THISHREF=http://c.moreover.com/click/here.pl%3fz2537481825%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038118&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038118&THISHREF=http://c.moreover.com/click/here.pl%3fz2537481825%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: King Pharmaceuticals Appoints Two New Members to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038115&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038115&THISHREF=http://c.moreover.com/click/here.pl%3fz2537477413%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038115&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038115&THISHREF=http://c.moreover.com/click/here.pl%3fz2537477413%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: King Pharmaceuticals Appoints Two New Members to Its Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038065&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038065&THISHREF=http://c.moreover.com/click/here.pl%3fz2537463879%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038065&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038065&THISHREF=http://c.moreover.com/click/here.pl%3fz2537463879%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: MarketResearch.com: "Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption" by GBI Research February 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036717&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036717&THISHREF=http://c.moreover.com/click/here.pl%3fz2536719435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036717&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036717&THISHREF=http://c.moreover.com/click/here.pl%3fz2536719435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Alnylam Pharmaceuticals receives 'Notice of Allowance' from USPTOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033438&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033438&THISHREF=http://c.moreover.com/click/here.pl%3fz2535202516%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033438&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033438&THISHREF=http://c.moreover.com/click/here.pl%3fz2535202516%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Piper Jaffray Names Inspire (ISPH) and Vertex Pharmaceuticals (VRTX) as Top Pickshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029883&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029883&THISHREF=http://c.moreover.com/click/here.pl%3fz2533320420%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029883&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029883&THISHREF=http://c.moreover.com/click/here.pl%3fz2533320420%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: New CEO and EUR2.3m Private Placement for Atacama Labs Oyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028753&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028753&THISHREF=http://c.moreover.com/click/here.pl%3fz2532843560%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028753&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028753&THISHREF=http://c.moreover.com/click/here.pl%3fz2532843560%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Phototherapy: Reports outline phototherapy research from F. Giuliani and colleagueshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027350&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027350&THISHREF=http://c.moreover.com/click/here.pl%3fz2532088397%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027350&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027350&THISHREF=http://c.moreover.com/click/here.pl%3fz2532088397%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: FDA Accepts Javelin Pharmaceuticals' Dyloject(TM) New Drug Application for Formal Reviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026156&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026156&THISHREF=http://c.moreover.com/click/here.pl%3fz2530411841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026156&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026156&THISHREF=http://c.moreover.com/click/here.pl%3fz2530411841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Strong operating performance for Roche in 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023958&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023958&THISHREF=http://c.moreover.com/click/here.pl%3fz2528518445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023958&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023958&THISHREF=http://c.moreover.com/click/here.pl%3fz2528518445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWorld Pharma News: Market Study Just Published: Isis Pharmaceuticals, Inc. - SWOT Analysishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024794&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024794&THISHREF=http://c.moreover.com/click/here.pl%3fz2529183209%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024794&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024794&THISHREF=http://c.moreover.com/click/here.pl%3fz2529183209%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: FDA OKs Javelin Pharmaceuticals' Dyloject NDA for Formal Review -...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024660&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024660&THISHREF=http://c.moreover.com/click/here.pl%3fz2529047355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024660&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024660&THISHREF=http://c.moreover.com/click/here.pl%3fz2529047355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: FDA OKs Javelin Pharmaceuticals' Dyloject NDA for Formal Reviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024670&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024670&THISHREF=http://c.moreover.com/click/here.pl%3fz2529051820%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024670&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MAJOR%20PHARMACEUTICALS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024670&THISHREF=http://c.moreover.com/click/here.pl%3fz2529051820%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: